# Eden Research laying down firm foundations for revenue growth

- Link: https://www.directorstalkinterviews.com/eden-research-laying-down-firm-foundations-for-revenue-growth/4121070519
- Published: 2022-06-29T07:21:55+01:00
- Author: Giles

**[Eden Research](https://www.directorstalkinterviews.com/company/eden-research-plc/eden.l)
plc **(LON:EDEN), the AIM-quoted company focused on sustainable biopesticides and
a plastic-free formulation technology for use in global crop protection, animal 
health and consumer products industries, will hold its Annual General Meeting today
at 12:00pm at 10 -11 Carlton House Terrace, London.

**At the meeting, Eden’s Chairman, Lykele van der Broek, will make the following
statement:**

“_The world has changed since we last came together in-person for Eden’s AGM. Despite
this unprecedented backdrop, Eden has continued to make positive strides that have
seen us lay down firm foundations for revenue growth._

_Over the past year, we have expanded our regulatory footprint for our flagship 
biopesticide products, Cedroz™ and Mevalone®, and diversified and strengthened the
business through increased crop and disease coverage in existing territories. This
has resulted in modest sales growth, despite the highly challenging environment,
with increased growth expected in 2022 and beyond._

_We eagerly await the approval of our two products and three active ingredients 
in the US, which will see us significantly expand our addressable market by entering
one of the largest agricultural markets in the world._

_2021 also saw us sign an exclusive agreement with Corteva Agriscience, the fourth
largest agriscience input company in the world. This partnership is strong and we
work hard together to bring our innovative seed treatment product to the market,
based on Eden’s active ingredients and Sustaine® microencapsulation technology._

_After a few challenging years, we have a positive outlook for 2022, with an anticipated
return to stronger year-on-year growth, despite some difficult conditions._

_We remain focused on registering and commercialising new products, including our
insecticide and seed treatment offerings, expanding the addressable market for our
existing product set, further developing the use of Sustaine with conventional agrochemical
partners, and expanding our product portfolio._

_We seek to achieve this using our relatively new in-house innovation capabilities,
which have reduced our dependence on third parties, and which help us to bring products
to market in a more efficient and cost-effective way._

_We are the only UK-listed company focused on sustainable biopesticides and plastic
free encapsulation technology. As regulators continue to regulate out conventional
crop protection products across the world, and farmers urgently seek alternatives
to maintain their crop yields, Eden’s products align perfectly with the course set
for the global industry. We think that this offers a significant opportunity for
our shareholders, commercial partners and growers and we look forward to working
together and sharing good news in the coming year.”_

**Company presentation**

After the conclusion of the formal business of the AGM, Sean Smith, Eden’s Chief
Executive Officer, will provide a short presentation to investors with an overview
of the Company’s progress and strategy.

At the beginning of the presentation, Eden will play a short video entitled “From
Lab to Leaf: The biopesticide registration journey”, which seeks to shine a light
on the journey that an Eden product goes through from conception to commercialisation
and seeks to raise awareness and understanding of this complex process.

The presentation and short video will be made available on the Company’s website
later today.

Share on:
